Levonorgestrel
CAS 797-63-7
Overview
Levonorgestrel is a synthetic progestin that binds to progesterone and androgen receptors. CAS: 797-63-7
Anant Labs manufacture and furnish high quality Levonorgestrel impurities for global markets. Our Levonorgestrel EP Impurities are used by API manufacturers and fully integrated pharmaceutical companies worldwide.
Technical Data
New Cat. No.ANTPRD6806
Old Cat. No.ANT-LVG-000
CAS797-63-7
Mol. FormulaC21H28O2
Mol. Weight312.45 g/mol
IUPAC(8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-17-hydroxy-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one
SMILESCC[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@]2(C#C)O)CCC4=CC(=O)CC[C@H]34
InChIInChI=1S/C21H28O2/c1-3-20-11-9-17-16-8-6-15(22)13-14(16)5-7-18(17)19(20)10-12-21(20,23)4-2/h2,13,16-19,23H,3,5-12H2,1H3/t16-,17+,18+,19-,20-,21-/m0/s1
InChI KeyWWYNJERNGUHSAO-XUDSTZEESA-N
Synonyms
D-(-)-NorgestrelD-NorgestrelDexnorgestrelLevonelleLevonovaMicrolutMicrovalNorgestonNorgestimate USP Related Compound A17-Ethynyl-18-methyl-19-nortestosteroneLevonorgestrel797-63-7MirenaNORPLANTPlan B(-)-NorgestrelJadelled(-)-NorgestrelLevonorgestrelum18-MethylnorethisteroneNorplant IINorLevoLilettaFallback SoloWy-5104LevosertMicrolutonSkylaNext choice17alpha-Ethynyl-18-homo-19-nortestosteronePlan B One-Step18-Methyl-17-alpha-ethynyl-19-nortestosteroneNorgestrel, (-)-Norplant System in Plastic ContainerKyleenaL-Norgestrel13-Ethyl-17-alpha-ethynylgon-4-en-17-beta-ol-3-one17alpha-Ethynyl-17-hydroxy-18-methylestr-4-en-3-oneBAY86-502817alpha-Ethynyl-13beta-ethyl-3-oxo-4-estren-17beta-olDTXSID303649613-Ethyl-17-alpha-ethynyl-17-beta-hydroxy-4-gonen-3-one5W7SIA7YZWNSC-74400717-alpha-Ethinyl-13-beta-ethyl-17-beta-hydroxy-4-estren-3-one13-Ethyl-17alpha-ethynylgon-4-en-17beta-ol-3-one(-)-13-Ethyl-17-hydroxy-18,19-dinor-17alpha-pregn-4-en-20-yn-3-one17-alpha-Ethynyl-13-ethyl-19-nortestosteroneCHEBI:6443(8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-17-hydroxy-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-oneDTXCID101649613-beta-Ethyl-17alpha-ethynyl-17beta-hydroxygon-4-en-3-one18,19-Dinorpregn-4-en-20-yn-3-one, 13-ethyl-17-hydroxy-, (17alpha)-(-)-13-Ethyl-17alpha-ethynyl-17-hydroxygon-4-en-3-oneAVIANE COMPONENT LEVONORGESTRELLEVORA COMPONENT LEVONORGESTRELPORTIA COMPONENT LEVONORGESTRELTWIRLA COMPONENT LEVONORGESTRELVIENVA COMPONENT LEVONORGESTRELKURVELO COMPONENT LEVONORGESTRELKYLEENA COMPONENT LEVONORGESTRELLESSINA COMPONENT LEVONORGESTRELMYZILRA COMPONENT LEVONORGESTRELTRIVORA COMPONENT LEVONORGESTRELELIFEMME COMPONENT LEVONORGESTRELENPRESSE COMPONENT LEVONORGESTRELMARLISSA COMPONENT LEVONORGESTRELNORDETTE COMPONENT LEVONORGESTRELORSYTHIA COMPONENT LEVONORGESTRELSETLAKIN COMPONENT LEVONORGESTRELAFIRMELLE COMPONENT LEVONORGESTRELQUARTETTE COMPONENT LEVONORGESTRELTRIPHASIL COMPONENT LEVONORGESTRELPostinor-2OPCICON ONE-STEP COMPONENT LEVONORGESTRELl NorgestrelD NorgestrelNorplant2OptionelleAfterpillEmerresEzinelleIsterandaJaydessUpostelleAfteraAfterPlanCuraeJulieReactSheWiseEmerres unaNorplant SystemAfter BangerAthentia NextMorning AfterStix RestartEmpowered ChoiceTake ActionHer StyleLevonelle-2Opcicon One-stepNew DayEContra One-StepPostDay One-StepLevonelle one stepMy Choice TMMy WayOption 2Econ Morning After(8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-17-hydroxy-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta(a)phenanthren-3-oneNorgestrel (-)-Next Choice One DoseEmergency ContraceptiveLevonorgestrel 1.5 mgRefChem:55482basic care levonorgestrelFem Choice morning afterITHAPPENZ MORNING AFTERLevonorgestrel Tablet, 1.5 mgG03AC03G03AD01AMAZON BASIC CARE LEVONORGESTRELLEADER Emergency Contraceptive Levonorgestrel(1S,2R,10R,11S,14R,15S)-15-ethyl-14-ethynyl-14-hydroxytetracyclo(8.7.0.02,7.011,15)heptadec-6-en-5-one(8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-17-hydroxy-1,2,6,7,8,9,10,11,12,13,14,15,16, 17-tetradecahydrocyclopenta(a) phenanthren-3-one212-349-8(17alpha)-13-Ethyl-17-hydroxy-18,19-dinorpregn-4-en-20-yn-3-onenorgestrel6533-00-2PostinorFollistreldl-NorgestrelOvretteNeogestLevonorgestrelum [INN-Latin]MonovarNorgestrel-(-)-DWy-3707NorgestrelumDTXSID3047477Norgestrel (-)-formNorplant 2MicrolutionOvranetteTriagynonTriciclorMFCD00199013MicrogynNordetTrigoaWy 3707Microgynon CDMicrogest EDLogynon EDOvral-LoLevlen EDMicrogynon 21Microgynon 28Trinordiol 21Trinordiol 28MLS000069491Minivlar 30Monofeme 28Neogynon 21Nordette 21Nordette 28Stediril 30(8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-17-hydroxy-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3(2H)-oneTrifeme 28PrevenLevora-21Levora-28Microgynon 30 EDTri-Levlen 21Rigevidon 21+7FH 122-A13-Ethyl-17-hydroxy-18,19-dinor-17alpha-pregn-4-en-20-yn-3-oneSH 850Triquilar EDLD norgestrel [French]Triphasil 21Triphasil 283J8Q1747Z2SH 70850NCGC00159349-02Norgestrelum [INN-Latin]SMR000059117Levonorgestrel implants13beta-Ethyl-17alpha-ethynyl-17beta-hydroxygon-4-en-3-oneE-Gen-CNorgestrel [Progestins]Ovoplex 30-150(+/-)-13-Ethyl-17alpha-ethynyl-17-hydroxygon-4-en-3-oneLevogel13-ethyl-17alpha-hydroxy-18,19-dinorpregn-4-en-20-yn-3-oneD-(-)-Norgestrel beta-D-GlucuronidePlan B One StepNorplant (TN)(8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-17-hydroxy-1,2,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-3H-cyclopenta[a]phenanthren-3-onerel-(8R,9S,10R,13S,14S,17R)-13-Ethyl-17-ethynyl-17-hydroxy-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3(2H)-oneOvrette (TN)Mirena (TN)CCRIS 6525CCRIS 9033Levonorgestrel (Levonelle)HSDB 3595HSDB 6483LNG-IUS(+/-)-NORGESTREL17alpha-Ethynyl-13-ethyl-19-nortestosteroneEINECS 212-349-8EINECS 229-433-5UNII-5W7SIA7YZWBRN 2391114FH-122Adl-13-beta-Ethyl-17-alpha-ethynyl-19-nortestosteroneSH-85019-Nortestosterone, 17-ethynyl-18-methyl-Levonorgestrel (JAN/USP/INN)Norgestrel CRSMirena;UNII-3J8Q1747Z2D -NorgestrelLevonorgestrel RS1lhvNSC-75725117-Ethynyl-18-methyl-19-nortestosterone Glucuronide; Levonorgestrel Glucuronide;Levonorgestrel CRSOral levonorgestrelCAS-797-63-7LNGSH-70850Prestwick_10918,19-Dinorpregn-4-en-20-yn-3-one, 13-ethyl-17-hydroxy-, (17alpha)-(+-)-(-)-LevonorgestrelLevonorgestrel [USAN:USP:INN:BAN]Levonorgestrel implantSkyla (TN)Norgestrel [USAN:USP:INN:BAN:JAN]BAY 86-5028NORGESTREL [MI]Opera_ID_552Levonorgestrel(Levonelle)NORGESTREL [INN]NORGESTREL [JAN]Dexnorgestrel (obsol.);dl-13-beta-Ethyl-17-alpha-ethynyl-17-beta-hydroxygon-4-en-3-onePrestwick0_000773Prestwick1_000773Prestwick2_000773Prestwick3_000773Levonorgestrel (Standard)NORGESTREL [HSDB]NORGESTREL [USAN]Intrauterine levonorgestrel17-beta-Hydroxy-18-methyl-19-nor-17-alpha-pregn-4-en-20-yn-3-oneNORGESTREL [VANDF](+-)-13-Ethyl-17-hydroxy-18,19-dinor-17alpha-pregn-4-en-20-yn-3-one(-)-Norgestrel, 98%NORGESTREL [MART.]CHEMBL1389LEVONORGESTREL [INN]LEVONORGESTREL [JAN]NORGESTREL [USP-RS]NORGESTREL [WHO-DD]BIDD:PXR0194SCHEMBL27597BSPBio_000846LEVONORGESTREL [HSDB]LEVONORGESTREL [USAN]MLS000759484MLS001074069MLS001423967LEVONORGESTREL [VANDF]SPBio_002785LEVONORGESTREL [MART.]BPBio1_000932GTPL2881Norgestrel (JP17/USP/INN)orb1305282orb1309186orb3139942LEVONORGESTREL [USP-RS]LEVONORGESTREL [WHO-DD]LEVONORGESTREL [WHO-IP]NORGESTREL [ORANGE BOOK]HY-B0257ROVRAL COMPONENT NORGESTREL17alpha-ethynyl-17beta-hydroxy-18a-homoestr-4-en-3-oneMSK8517NORGESTREL [EP MONOGRAPH]IMPLANT WITH LEVONORGESTRELDTXCID401079284HMS1570K08HMS2051M08HMS2090O06HMS2097K08HMS2232H06HMS2232K12HMS3649J10HMS3714K08HMS3886K18NORGESTREL [USP MONOGRAPH](1S,2R,10R,11S,14R,15S)-15-ethyl-14-ethynyl-14-hydroxytetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-6-en-5-oneCRYSELLE COMPONENT NORGESTRELD-(-)-Norgestrel b-D-GlucuronideHY-B0257NORGESTREL (-)-FORM [MI]LEVONORGESTREL [ORANGE BOOK]Tox21_111593Tox21_202872Tox21_303623Tox21_303658BDBM50410522EBC-11102LEVONORGESTREL [EP MONOGRAPH]LEVONORGESTREL [USP IMPURITY]LMST02030119MSK2222-100AMSK8517-100ANSC744007s1727s5709ALESSE COMPONENT LEVONORGESTRELD(-)-Norgestrel, analytical standardLEVONORGESTREL [USP MONOGRAPH]LYBREL COMPONENT LEVONORGESTRELNorgestrel for system suitability CRSPREVEN COMPONENT LEVONORGESTREL18,19-Dinor-17-alpha-pregn-4-en-20-yn-3-one, 13-ethyl-17-hydroxy-AKOS015894913LEVLITE COMPONENT LEVONORGESTRELMSK2222-1000AMSK8517-1000APLASTIC IUD WITH LEVONORGESTRELTox21_111593_1CCG-100853DB00367FN26454FN26455LEVONORGESTRELUM [WHO-IP LATIN]NC00103NSC 744007NSC 757251NSC 75965318,19-Dinor-17-alpha-pregn-4-en-20-yn-3-one, 13-ethyl-17-hydroxy-, (+-)-ALTAVERA COMPONENT LEVONORGESTRELD-(-)-Norgestrel - Bio-X trade markLEVONEST COMPONENT LEVONORGESTRELQUASENSE COMPONENT LEVONORGESTREL[18,(17.alpha.)-(-)-]INTROVALE COMPONENT LEVONORGESTRELNCGC00159349-03NCGC00159349-05NCGC00256735-01NCGC00257283-01NCGC00260418-01SEASONALE COMPONENT LEVONORGESTREL(1R,3aS,3bR,9aR,9bS,11aS)-11a-ethyl-1-ethynyl-1-hydroxy-1H,2H,3H,3aH,3bH,4H,5H,7H,8H,9H,9aH,9bH,10H,11H,11aH-cyclopenta[a]phenanthren-7-oneBN300105SEASONIQUE COMPONENT LEVONORGESTRELSMR000653526CAS-6533-00-2CLIMARA PRO COMPONENT LEVONORGESTRELLevonorgestrel; Norgestimate EP Impurity BLevonorgestrel for system suitability 1 CRSLevonorgestrel for system suitability 2 CRSLOSEASONIQUE COMPONENT LEVONORGESTRELLevonorgestrel norgestrel D-Norgestrel MirenaN0889NORGESTIMATE IMPURITY B [EP IMPURITY]NS00002177NS00067059Levonorgestrel 100 microg/mL in AcetonitrileC08149C08153D00950D00954EN300-122613Norgestrel Solution in Acetonitrile, 100ug/mLNorgestrel Solution in Acetonitrile, 1000ug/mLF358122Q416950SR-01000759218SR-01000946725(-)-17alpha-Ethynyl-18-methyl-19-nortestosteroneSR-01000759218-5SR-01000946725-1BRD-K35189033-001-03-0BRD-K35189033-001-26-1D-(-)-Norgestrel Solution in Acetonitrile, 100ug/mL13-ethyl-17alpha-ethynyl-17beta-hydroxygon-4-en-3-oneD-(-)-Norgestrel Solution in Acetonitrile, 1000ug/mLZ1544404028(+/-)-13-Ethyl-17a-ethynyl-17-hydroxygon-4-en-3-one13beta-ethyl-17alpha-ethynyl-17-hydroxy-gon-4-en-3-oneNorgestrel Working Standard (Secondary Reference Standard)13beta-ethyl-17alpha-ethynyl-17beta-hydroxy-gon-4-en-3-oneLevonorgestrel Working Standard (Secondary Reference Standard)Levonorgestrel, British Pharmacopoeia (BP) Reference StandardLevonorgestrel, European Pharmacopoeia (EP) Reference StandardLevonorgestrel, United States Pharmacopeia (USP) Reference Standard(-)-18,19-Dinor-13beta-ethyl-17beta-hydroxy-4-pregnen-20-yn-3-one(17a)-(+/-)-13-Ethyl-17-hydroxy-18,19-dinorpregn-4-en-20-yn-3-one[(-)-13-ethyl-17-hydroxy-18,19-dinor-17a-pregn-4-en-20-yn-3-one( inverted exclamation markA)-13-Ethyl-17|A-ethynyl-17-hydroxygon-4-en-3-one(+/-)-13-ETHYL-17-HYDROXY-18,19-DINOR-17.ALPHA.-PREGN-4-EN-20-YN-3-ONE(-)-13-ETHYL-17-HYDROXY-18,19-DINOR-17.ALPHA.-PREGN-4-EN-20-YN-3-ONE18,19-DINORPREGN-4-EN-20-YN-3-ONE, 13-ETHYL-17-HYDROXY-, (17.ALPHA.)-(+/-)-18,19-DINORPREGN-4-EN-20-YN-3-ONE, 13-ETHYL-17-HYDROXY-, (17.ALPHA.)-(-)-Levonorgestrel for system suitability 2, European Pharmacopoeia (EP) Reference StandardLevonorgestrel, Pharmaceutical Secondary Standard; Certified Reference Material(1R,3aS,3bR,9aR,9bS,11aS)-11a-Ethyl-1-ethynyl-1-hydroxy-1,2,3,3a,3b,4,5,8,9,9a,9b,10,11,11a-tetradecahydro-7H-cyclopenta[a]phenanthren-7-one(8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-17-hydroxy- 1,2,6,7,8,9,10,11,12,13,14,15,16, 17- tetradecahydrocyclopenta[a] phenanthren-3-one(8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-17-hydroxy-1,2,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-3H-cyclopenta[a]phenanthren-3-one (non-preferred name)rel-(1R,3aS,3bR,9aR,9bS,11aS)-11a-Ethyl-1-ethynyl-1-hydroxy-1,2,3,3a,3b,4,5,8,9,9a,9b,10,11,11a-tetradecahydro-7H-cyclopenta[a]phenanthren-7-one